Genome-wide profiling using single-nucleotide polymorphism arrays identifies novel chromosomal imbalances in pediatric glioblastomas.
暂无分享,去创建一个
A. Montpetit | C. Polychronakos | H. Qu | C. Hawkins | O. Delattre | B. Ge | S. Albrecht | P. Hauser | M. Garami | L. Bognár | D. Faury | N. Jabado | D. Barnett | J. Farmer | K. Jacob | Sarah Fatet | L. Solomon | Zoltan Hansely | R. Mio | Robert Mio | L. Bognár
[1] Joshua M. Korn,et al. Comprehensive genomic characterization defines human glioblastoma genes and core pathways , 2008, Nature.
[2] L. Chin,et al. A comparison of DNA copy number profiling platforms. , 2008, Cancer research.
[3] E. Lander,et al. Assessing the significance of chromosomal aberrations in cancer: Methodology and application to glioma , 2007, Proceedings of the National Academy of Sciences.
[4] Joseph T. Glessner,et al. A genome-wide association study identifies KIAA0350 as a type 1 diabetes gene , 2007, Nature.
[5] Jian Luo,et al. GCIP/CCNDBP1, a helix–loop–helix protein, suppresses tumorigenesis , 2007, Journal of cellular biochemistry.
[6] Christopher B. Miller,et al. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia , 2007, Nature.
[7] P. Liberski,et al. Molecular profiling identifies prognostic subgroups of pediatric glioblastoma and shows increased YB-1 expression in tumors. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] Rameen Beroukhim,et al. Single nucleotide polymorphism array analysis of cancer , 2007, Current opinion in oncology.
[9] Mei He,et al. Cancer development and progression. , 2007, Advances in experimental medicine and biology.
[10] K. Wong,et al. Genome-wide allelic imbalance analysis of pediatric gliomas by single nucleotide polymorphic allele array. , 2006, Cancer research.
[11] L. Chin,et al. Marked genomic differences characterize primary and secondary glioblastoma subtypes and identify two distinct molecular and clinical secondary glioblastoma entities. , 2006, Cancer research.
[12] Fenghua Liu,et al. A genome-wide screen reveals functional gene clusters in the cancer genome and identifies EphA2 as a mitogen in glioblastoma. , 2006, Cancer research.
[13] C. James,et al. Rarity of PTEN deletions and EGFR amplification in malignant gliomas of childhood: results from the Children's Cancer Group 945 cohort. , 2006, Journal of neurosurgery.
[14] Yuri Kotliarov,et al. High-resolution global genomic survey of 178 gliomas reveals novel regions of copy number alteration and allelic imbalances. , 2006, Cancer research.
[15] K. Gunderson,et al. High-resolution genomic profiling of chromosomal aberrations using Infinium whole-genome genotyping. , 2006, Genome research.
[16] Céline Rouveirol,et al. VAMP: Visualization and analysis of array-CGH, transcriptome and other molecular profiles , 2006, Bioinform..
[17] Thomas D. Wu,et al. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. , 2006, Cancer cell.
[18] A. Broniscer. Past, Present, and Future Strategies in the Treatment of High-Grade Glioma in Children , 2006, Cancer investigation.
[19] K. Frazer,et al. Common deletions and SNPs are in linkage disequilibrium in the human genome , 2006, Nature Genetics.
[20] Y. Leea,et al. Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target , 2006 .
[21] D. Conrad,et al. A high-resolution survey of deletion polymorphism in the human genome , 2006, Nature Genetics.
[22] T. MacDonald,et al. Pediatric High-grade Glioma: Molecular Genetic Clues for Innovative Therapeutic Approaches , 2005, Journal of Neuro-Oncology.
[23] Francis Galibert,et al. Construction of a 2-Mb resolution BAC microarray for CGH analysis of canine tumors. , 2005, Genome research.
[24] Han G Brunner,et al. Identification of disease genes by whole genome CGH arrays. , 2005, Human molecular genetics.
[25] L. Recht,et al. High-resolution genome-wide mapping of genetic alterations in human glial brain tumors. , 2005, Cancer research.
[26] M. West,et al. Gene expression profiling and genetic markers in glioblastoma survival. , 2005, Cancer research.
[27] K. Gunderson,et al. A genome-wide scalable SNP genotyping assay using microarray technology , 2005, Nature Genetics.
[28] K. Aldape,et al. Integrated array-comparative genomic hybridization and expression array profiles identify clinically relevant molecular subtypes of glioblastoma. , 2005, Cancer research.
[29] M. Olivier. A haplotype map of the human genome. , 2003, Nature.
[30] M. Olivier. A haplotype map of the human genome , 2003, Nature.
[31] K. Gunderson,et al. Illumina, Inc. , 2005, Pharmacogenomics.
[32] K. Honda,et al. Integration of interferon-alpha/beta signalling to p53 responses in tumour suppression and antiviral defence. , 2003, Nature.
[33] S. Elledge,et al. 53BP1, a Mediator of the DNA Damage Checkpoint , 2002, Science.
[34] L. Parada,et al. The Molecular and Genetic Basis of Neurological Tumours , 2002, Nature Reviews Cancer.
[35] B. Harding,et al. Identification of extensive genomic loss and gain by comparative genomic hybridisation in malignant astrocytoma in children and young adults , 2001, Genes, chromosomes & cancer.
[36] H. Jürgens,et al. Pediatric high-grade astrocytomas show chromosomal imbalances distinct from adult cases. , 2001, The American journal of pathology.
[37] P. Ferrara,et al. HUMAN 76P : A NEW MEMBER OF THE GAMMA -TUBULIN-ASSOCIATED PROTEIN FAMILY , 1999 .
[38] B J Williams,et al. Comparative genomic hybridization. , 1996, Methods in molecular medicine.
[39] K. Kinzler,et al. Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. , 1987, Proceedings of the National Academy of Sciences of the United States of America.